SIMZEPTIN
Welcome to the Brand page for “SIMZEPTIN”, which is offered here for Antifungal preparations; dermatological pharmaceutical products; pharmaceutical preparations for treatment of cardiovascular, central nervous system, endocrine, gastrointestinal, genetic immunological, infectious, inflammatory, menopausal, metabolic, autoimmune, musculoskeletal, neurological, ophthalmological, psychiatric, respiratory, urogenital, urological and viral diseases and disorders; pharmaceutical preparations for the treatment of erectile dysfunction, sexual dysfunction, cancer, pain and diabetes; pharmaceutical preparations for use in hematology; smoking cessation preparations; human vaccine preparations; pharmaceutical preparations and substances for the treatment of damaged skin and tissue;.
Its status is currently believed to be active. Its class is unavailable. “SIMZEPTIN” is believed to be currently owned by “Pfizer Inc.”
| Owner: |
PFIZER INC.
Owner Details |
|---|---|
| Description: |
Antifungal preparations; Dermatological pharmaceutical products; Pharmaceutical preparations for treatment of cardiovascular, central nervous system, endocrine, gastrointestinal, genetic immunological, infectious, inflammatory, menopausal, metabolic, autoimmune, musculoskeletal, neurological, ophthalmological, psychiatric, respiratory, urogenital, urological and viral diseases and disorders; Pharmaceutical preparations for the treatment of erectile dysfunction, sexual dysfunction, cancer, pain and diabetes; Pharmaceutical preparations for use in hematology; Smoking cessation preparations; Human vaccine preparations; Pharmaceutical preparations and substances for the treatment of damaged skin and tissue;
|
| Categories: | ANTIFUNGAL PREPARATIONS |
